Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
Journal of Dental Education|September 11, 2025
Bridging the Gap Between Training and Reality: A Dental Scientist Trainee PerspectiveKazune Pax, Seung Jin Jang, Caris M Smith, et al.Bone Research|May 29, 2025
RUNX2 is essential for maintaining synchondrosis chondrocytes and cranial base growthShawn A Hallett, Ashley Dixon, Isabella Marrale, et al.Development (Cambridge, England)|November 25, 2020
An Irf6-Esrp1/2 regulatory axis controls midface morphogenesis in vertebratesShannon H Carroll, Claudio Macias Trevino, Edward B Li, et al.Nature Communications|January 18, 2020
A Wnt-mediated transformation of the bone marrow stromal cell identity orchestrates skeletal regenerationYuki Matsushita, Mizuki Nagata, Kenneth M Kozloff, et al.Oncology Research|January 1, 1996
alpha-(3,4-dimethyoxyphenyl)-3,4-dihydro-6,7-dimethoxy-alpha- [(4-methylphenyl)thio]-2(1H)-isoquinolineheptanenitrile (CL 329,753): a novel chemosensitizing agent for P-glycoprotein-mediated resistance with improved biological properties compared with verapamil and cyclosporine AL M Greenberger, K I Collins, T Annable, et al.Journal of Medicinal Chemistry|September 17, 1993
Preparation of substituted N-phenyl-4-aryl-2-pyrimidinamines as mediator release inhibitorsR Paul, W A Hallett, J W Hanifin, et al.Elife|January 19, 2023
Control of craniofacial development by the collagen receptor, discoidin domain receptor 2Fatma F Mohamed, Chunxi Ge, Shawn A Hallett, et al.Journal of Medicinal Chemistry|April 11, 1990
Preparation of triazolo[1,5-c]pyrimidines as potential antiasthma agentsJ B Medwid, R Paul, J S Baker, et al.Journal of Medicinal Chemistry|November 1, 1985
Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agentsR Paul, J A Brockman, W A Hallett, et al.Development (Cambridge, England)|December 24, 2010
Dishevelled-associated activator of morphogenesis 1 (Daam1) is required for heart morphogenesisDeqiang Li, Mark A Hallett, Wuqiang Zhu, et al.Pageof 10